![Ann Thorell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann Thorell
Finansdirektör/CFO på
SERES THERAPEUTICS, INC.
Förmögenhet: - $ per 2026-06-30
Profil
Ann Marella Thorell is currently Director at Living Beyond Breast Cancer, Director at ApcinteX Ltd. since 2021, and Chief Financial Officer & Executive Vice President at Seres Therapeutics, Inc. starting in 2024.
Former roles include Chairman at Vallon Pharmaceuticals, Inc. from 2022 to 2023; COO, CFO, Secretary & Executive Director at Realm Therapeutics Plc from 2014 to 2019; Director at Capella Bioscience Ltd. and Z Factor Ltd. from 2021 to 2022; Independent Director at ESSA Pharma, Inc. from 2019 to 2025 and at Carisma Therapeutics, Inc. from 2024 to 2025; CFO, Treasurer, SVP & Chief Accounting Officer at Evelo Biosciences, Inc. in 2023; President at Thorell Consulting; Chief Financial Officer at Palladio Biosciences, Inc. from 2019 to 2021; and Chief Accounting Officer at Centessa Pharmaceuticals Plc from 2021 to 2022.
Education includes undergraduate studies at Lehigh University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-08 | 0 ( -.--% ) | - $ | 2026-06-30 | |
| 2025-05-31 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Ann Thorell
| Företag | Position | Start |
|---|---|---|
| SERES THERAPEUTICS, INC. | Finansdirektör/CFO | 2024-03-25 |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology Manufactures novel hemophilia drugs | Direktör/Styrelseledamot | 2021-01-29 |
Living Beyond Breast Cancer
 Living Beyond Breast Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a a non-profit organization that provides breast cancer patient support services | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Ann Thorell
| Företag | Position | Slut |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-12-31 |
| ESSA PHARMA INC. | Direktör/Styrelseledamot | 2025-10-09 |
| EVELO BIOSCIENCES, INC. | Finansdirektör/CFO | 2023-11-20 |
| GRI BIOPAR | Ordförande | 2023-04-21 |
| CENTESSA PHARMACEUTICALS PLC | Comptroller/Controller/Revisor | 2022-07-31 |
Ann Thorells utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
50
Första gradens relationer
14
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 14 |
|---|---|
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops proprietary immunomodulatory products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Living Beyond Breast Cancer
Living Beyond Breast Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a a non-profit organization that provides breast cancer patient support services | Commercial Services |
ESSA Pharma, Inc.
 ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Develops novel medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease | Health Technology |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Engages in research and development of therapeutic agents to treat alpha-1 antitrypsin deficiency | Health Technology |
ApcinteX Ltd.
ApcinteX Ltd. BiotechnologyHealth Technology Manufactures novel hemophilia drugs | Health Technology |
Thorell Consulting
 Thorell Consulting Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
